Basics United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients. IPO Date: June 17, 1999 Sector: Healthcare Industry: Biotech Market Cap: $13.23B Activated in VL: True Average Daily Range Avg Daily Range: $1.59 | 1.39% Avg Daily Range (30 D): $3.41 | 1.17% Avg Daily Range (90 D): $4.17 | 1.39% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): .46M Avg Daily Volume (90 D): .38M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 32 Avg Trade Size (Sh.) (90 D): 30 Institutional Trades Total Inst.Trades: 14,247 Avg Inst. Trade: $4.63M Avg Inst. Trade (30 D): $16.04M Avg Inst. Trade (90 D): $17.5M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $8.87M Avg Closing Trade (30 D): $30.07M Avg Closing Trade (90 D): $27.54M Avg Closing Volume: 57.79K     News Jul 17, 2025 @ 6:52 PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ... Source: Rosen Law Firm Jun 15, 2025 @ 1:08 PM AppLovin, Chewy And Carvana Are Among Top 11 Large... Source: Mohit Manghnani May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation Financials   TTM Q1 2025 Q4 2024 Basic EPS $27.08 $7.18 $6.71 Diluted EPS $25.08 $6.63 $6.21 Revenue $ 2.99B $ 794.4M $ 735.9M Gross Profit $ 2.66B $ 701.9M $ 660M Net Income / Loss $ 1.21B $ 322.2M $ 301.3M Operating Income / Loss $ 1.4B $ 382.8M $ 357.7M Cost of Revenue $ 329.3M $ 92.5M $ 75.9M Net Cash Flow $ 648.4M $ 202.7M $ 143.3M PE Ratio 12.16     Splits Sep 23, 2009:   2:1